Table 1

Patients enrolled in this study

SubgroupNo. of patients (families)
Total (families)Age, y (range)Female/male ratio
WUMCReferred*
DC 1 (1) 21 (11) 22 (12) 28.3 (1.5-52.1) 0.47 
DBA 13 (9) 28 (24) 41 (33) 11.8 (0.2-61.5) 0.67 
SDS 5 (5) 0 (0) 5 (5) 20.1 (2.3-41.4) 0.50 
MDS 25 (24) 6 (5) 31 (29) 46.8 (0.5-86.6) 0.88 
PNH 29 (29) 16 (16) 45 (45) 36.6 (8.0-70.8) 3.09 
AA 67 (66) 28 (25) 95 (91) 17.9 (0.05-75.8) 0.69 
Other IBMF 7 (6) 1 (1) 8 (7) 9.3 (0.08-28.9) 1.67 
All 147 (140) 100 (82) 247 (221) 23.5 (0.05-86.6) 0.89 
SubgroupNo. of patients (families)
Total (families)Age, y (range)Female/male ratio
WUMCReferred*
DC 1 (1) 21 (11) 22 (12) 28.3 (1.5-52.1) 0.47 
DBA 13 (9) 28 (24) 41 (33) 11.8 (0.2-61.5) 0.67 
SDS 5 (5) 0 (0) 5 (5) 20.1 (2.3-41.4) 0.50 
MDS 25 (24) 6 (5) 31 (29) 46.8 (0.5-86.6) 0.88 
PNH 29 (29) 16 (16) 45 (45) 36.6 (8.0-70.8) 3.09 
AA 67 (66) 28 (25) 95 (91) 17.9 (0.05-75.8) 0.69 
Other IBMF 7 (6) 1 (1) 8 (7) 9.3 (0.08-28.9) 1.67 
All 147 (140) 100 (82) 247 (221) 23.5 (0.05-86.6) 0.89 

WUMC indicates Washington University Medical Center; DC, dyskeratosis congenita; DBA, Diamond Blackfan syndrome; SDS, Shwachman-Diamond syndrome; MDS, myelodysplastic syndrome; PNH, paroxysmal nocturnal hemoglobinuria; AA, aplastic anemia; and IBMF, inherited bone marrow failure.

*

Patients enrolled through institutions outside Washington University.

or Create an Account

Close Modal
Close Modal